Shahzad Shaefi, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Oxygen Inhalation Therapy | 4 | 2021 | 389 | 1.630 |
Why?
|
Cardiac Surgical Procedures | 16 | 2023 | 3584 | 1.490 |
Why?
|
Extracorporeal Membrane Oxygenation | 6 | 2023 | 1430 | 1.060 |
Why?
|
Hyperoxia | 2 | 2018 | 248 | 1.040 |
Why?
|
Oxygen | 6 | 2022 | 4179 | 1.020 |
Why?
|
Respiratory Insufficiency | 6 | 2023 | 1211 | 0.930 |
Why?
|
Methyl Ethers | 2 | 2022 | 195 | 0.920 |
Why?
|
Anesthetics, Inhalation | 3 | 2022 | 567 | 0.830 |
Why?
|
Propofol | 4 | 2022 | 606 | 0.800 |
Why?
|
Coronary Artery Bypass | 6 | 2019 | 2265 | 0.760 |
Why?
|
Cardiopulmonary Bypass | 6 | 2022 | 1075 | 0.730 |
Why?
|
Isoflurane | 1 | 2022 | 378 | 0.660 |
Why?
|
Tidal Volume | 3 | 2018 | 484 | 0.650 |
Why?
|
Intraoperative Care | 2 | 2021 | 759 | 0.650 |
Why?
|
Resource Allocation | 1 | 2020 | 345 | 0.620 |
Why?
|
Respiration, Artificial | 7 | 2023 | 2598 | 0.610 |
Why?
|
Vasoplegia | 1 | 2017 | 15 | 0.600 |
Why?
|
Blood Gas Analysis | 1 | 2017 | 376 | 0.560 |
Why?
|
Delirium | 7 | 2023 | 1645 | 0.550 |
Why?
|
Critical Illness | 10 | 2023 | 2687 | 0.530 |
Why?
|
Thoracic Wall | 1 | 2018 | 198 | 0.530 |
Why?
|
Thoracic Surgery | 1 | 2022 | 706 | 0.510 |
Why?
|
Anesthesiology | 2 | 2022 | 1082 | 0.490 |
Why?
|
Hospital Mortality | 10 | 2021 | 5370 | 0.490 |
Why?
|
Acute Lung Injury | 1 | 2018 | 369 | 0.460 |
Why?
|
Vascular Surgical Procedures | 3 | 2018 | 1458 | 0.450 |
Why?
|
Critical Care | 5 | 2023 | 2677 | 0.430 |
Why?
|
Intensive Care Units | 12 | 2021 | 3699 | 0.410 |
Why?
|
Monitoring, Intraoperative | 2 | 2017 | 934 | 0.390 |
Why?
|
Postoperative Care | 1 | 2018 | 1465 | 0.390 |
Why?
|
Tissue Plasminogen Activator | 3 | 2021 | 1187 | 0.380 |
Why?
|
Shock, Cardiogenic | 2 | 2022 | 714 | 0.360 |
Why?
|
Cost of Illness | 1 | 2020 | 1911 | 0.360 |
Why?
|
Surgical Procedures, Operative | 2 | 2020 | 1863 | 0.350 |
Why?
|
Dexmedetomidine | 3 | 2019 | 316 | 0.340 |
Why?
|
Prone Position | 3 | 2021 | 195 | 0.330 |
Why?
|
Bronchoscopy | 4 | 2020 | 898 | 0.320 |
Why?
|
Pandemics | 7 | 2021 | 8499 | 0.320 |
Why?
|
Anesthesia | 5 | 2019 | 1563 | 0.310 |
Why?
|
Patient Positioning | 3 | 2021 | 325 | 0.290 |
Why?
|
Postoperative Complications | 11 | 2023 | 15438 | 0.270 |
Why?
|
Cognition | 5 | 2020 | 6862 | 0.260 |
Why?
|
Lung Injury | 2 | 2022 | 423 | 0.260 |
Why?
|
Analgesics, Non-Narcotic | 2 | 2019 | 371 | 0.250 |
Why?
|
Positive-Pressure Respiration | 3 | 2018 | 631 | 0.250 |
Why?
|
Hypnotics and Sedatives | 3 | 2019 | 1162 | 0.240 |
Why?
|
Acetaminophen | 2 | 2019 | 549 | 0.240 |
Why?
|
Physicians | 1 | 2022 | 4550 | 0.230 |
Why?
|
Humans | 77 | 2024 | 752810 | 0.230 |
Why?
|
Perioperative Care | 3 | 2020 | 1015 | 0.220 |
Why?
|
Fibrin Fibrinogen Degradation Products | 2 | 2023 | 419 | 0.210 |
Why?
|
Coronary Artery Disease | 3 | 2018 | 6591 | 0.210 |
Why?
|
Aged | 30 | 2023 | 166705 | 0.190 |
Why?
|
Length of Stay | 5 | 2022 | 6372 | 0.190 |
Why?
|
Martial Arts | 1 | 2021 | 28 | 0.190 |
Why?
|
Thrombosis | 3 | 2021 | 3018 | 0.180 |
Why?
|
Midodrine | 1 | 2020 | 24 | 0.180 |
Why?
|
Male | 39 | 2023 | 355160 | 0.180 |
Why?
|
Treatment Outcome | 17 | 2021 | 64288 | 0.180 |
Why?
|
Coronary Artery Bypass, Off-Pump | 2 | 2018 | 65 | 0.170 |
Why?
|
Female | 38 | 2023 | 386339 | 0.170 |
Why?
|
Time | 1 | 2021 | 544 | 0.160 |
Why?
|
Hospitalization | 5 | 2021 | 10628 | 0.160 |
Why?
|
Sepsis | 3 | 2019 | 2590 | 0.160 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3066 | 0.160 |
Why?
|
Intra-Aortic Balloon Pumping | 2 | 2022 | 225 | 0.160 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3185 | 0.160 |
Why?
|
Double-Blind Method | 4 | 2021 | 12322 | 0.150 |
Why?
|
Middle Aged | 31 | 2023 | 217250 | 0.150 |
Why?
|
Partial Pressure | 1 | 2017 | 245 | 0.150 |
Why?
|
Academic Medical Centers | 2 | 2020 | 2714 | 0.150 |
Why?
|
Blood Coagulation Disorders | 1 | 2021 | 346 | 0.150 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 248 | 0.150 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 1 | 2018 | 91 | 0.150 |
Why?
|
Methylene Blue | 1 | 2017 | 151 | 0.140 |
Why?
|
Cohort Studies | 12 | 2023 | 40996 | 0.140 |
Why?
|
Intubation, Intratracheal | 2 | 2019 | 1319 | 0.140 |
Why?
|
Heme Oxygenase-1 | 1 | 2019 | 363 | 0.140 |
Why?
|
Apyrase | 1 | 2019 | 369 | 0.140 |
Why?
|
Boston | 6 | 2020 | 9235 | 0.140 |
Why?
|
Tracheostomy | 1 | 2020 | 415 | 0.140 |
Why?
|
Hospitals, Community | 1 | 2018 | 361 | 0.130 |
Why?
|
Respiration Disorders | 1 | 2019 | 369 | 0.130 |
Why?
|
United States | 13 | 2023 | 71434 | 0.130 |
Why?
|
Aneurysm, Ruptured | 1 | 2021 | 450 | 0.130 |
Why?
|
Meditation | 1 | 2019 | 247 | 0.130 |
Why?
|
Brain Injuries | 2 | 2018 | 2034 | 0.130 |
Why?
|
Ethics, Medical | 1 | 2020 | 788 | 0.130 |
Why?
|
Anesthetics | 1 | 2021 | 518 | 0.130 |
Why?
|
Frail Elderly | 1 | 2020 | 731 | 0.120 |
Why?
|
Severity of Illness Index | 4 | 2021 | 15695 | 0.120 |
Why?
|
Surgery, Computer-Assisted | 1 | 2003 | 1005 | 0.120 |
Why?
|
Intracranial Pressure | 1 | 2017 | 321 | 0.120 |
Why?
|
Vulnerable Populations | 1 | 2020 | 694 | 0.120 |
Why?
|
Burnout, Professional | 1 | 2023 | 681 | 0.120 |
Why?
|
Angiotensin II | 1 | 2017 | 853 | 0.120 |
Why?
|
Hypotension | 1 | 2020 | 878 | 0.120 |
Why?
|
Myocardial Revascularization | 1 | 2018 | 841 | 0.120 |
Why?
|
Needs Assessment | 1 | 2020 | 1139 | 0.120 |
Why?
|
Medicare | 2 | 2023 | 6689 | 0.110 |
Why?
|
Pneumothorax | 1 | 2017 | 374 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2023 | 10200 | 0.110 |
Why?
|
Adult | 23 | 2023 | 217168 | 0.110 |
Why?
|
Geriatric Assessment | 1 | 2021 | 1387 | 0.110 |
Why?
|
Lung | 4 | 2020 | 9899 | 0.110 |
Why?
|
Leukocytes, Mononuclear | 1 | 2020 | 1820 | 0.110 |
Why?
|
Infection Control | 1 | 2020 | 971 | 0.110 |
Why?
|
Hospitals, Urban | 1 | 2015 | 494 | 0.110 |
Why?
|
Proteomics | 2 | 2023 | 3750 | 0.100 |
Why?
|
Catheterization, Central Venous | 1 | 2017 | 520 | 0.100 |
Why?
|
Conscious Sedation | 2 | 2014 | 519 | 0.100 |
Why?
|
Deep Sedation | 1 | 2013 | 117 | 0.100 |
Why?
|
Heart Valve Prosthesis Implantation | 2 | 2019 | 1588 | 0.100 |
Why?
|
Clinical Protocols | 1 | 2017 | 1436 | 0.100 |
Why?
|
Neurosurgical Procedures | 1 | 2003 | 2024 | 0.100 |
Why?
|
Prospective Studies | 7 | 2022 | 53833 | 0.100 |
Why?
|
Heart-Assist Devices | 1 | 2022 | 1270 | 0.100 |
Why?
|
Thrombolytic Therapy | 1 | 2020 | 2099 | 0.100 |
Why?
|
Intracranial Aneurysm | 1 | 2021 | 1224 | 0.090 |
Why?
|
Heart Diseases | 1 | 2024 | 2790 | 0.090 |
Why?
|
Killer Cells, Natural | 1 | 2020 | 2174 | 0.090 |
Why?
|
Time Factors | 8 | 2020 | 39885 | 0.090 |
Why?
|
Weight Gain | 1 | 2021 | 2329 | 0.090 |
Why?
|
Terrorism | 1 | 2013 | 212 | 0.090 |
Why?
|
Heart Arrest | 1 | 2020 | 1487 | 0.090 |
Why?
|
Pneumonia | 1 | 2022 | 2122 | 0.090 |
Why?
|
Organ Transplantation | 1 | 2020 | 1134 | 0.090 |
Why?
|
Aged, 80 and over | 11 | 2022 | 58347 | 0.090 |
Why?
|
Risk Factors | 13 | 2020 | 73418 | 0.090 |
Why?
|
Occupational Exposure | 1 | 2020 | 1798 | 0.090 |
Why?
|
Preoperative Care | 1 | 2019 | 2234 | 0.090 |
Why?
|
Weight Loss | 1 | 2021 | 2649 | 0.080 |
Why?
|
Klippel-Feil Syndrome | 1 | 2009 | 19 | 0.080 |
Why?
|
Ultrasonography, Interventional | 1 | 2017 | 1486 | 0.080 |
Why?
|
Registries | 3 | 2021 | 8363 | 0.080 |
Why?
|
Risk | 1 | 2020 | 9613 | 0.080 |
Why?
|
Anticoagulants | 2 | 2021 | 4830 | 0.080 |
Why?
|
Retrospective Studies | 10 | 2023 | 79160 | 0.080 |
Why?
|
Wounds and Injuries | 1 | 2020 | 2426 | 0.070 |
Why?
|
Lung Diseases | 1 | 2017 | 1899 | 0.070 |
Why?
|
Epilepsy | 1 | 2003 | 3314 | 0.070 |
Why?
|
Health Personnel | 1 | 2020 | 3270 | 0.070 |
Why?
|
Cerebrovascular Circulation | 1 | 2017 | 2723 | 0.070 |
Why?
|
Nephrectomy | 1 | 2012 | 1000 | 0.070 |
Why?
|
Hemodynamics | 1 | 2017 | 4173 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2020 | 4502 | 0.070 |
Why?
|
Patient Selection | 1 | 2018 | 4239 | 0.070 |
Why?
|
Anxiety | 2 | 2019 | 4456 | 0.060 |
Why?
|
Logistic Models | 3 | 2019 | 13277 | 0.060 |
Why?
|
Cerebral Hemorrhage | 1 | 2017 | 2646 | 0.060 |
Why?
|
Palliative Care | 1 | 2020 | 3578 | 0.060 |
Why?
|
Hospitals | 2 | 2019 | 3915 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39089 | 0.060 |
Why?
|
Cytokines | 1 | 2020 | 7239 | 0.060 |
Why?
|
Quality Improvement | 1 | 2020 | 3796 | 0.060 |
Why?
|
Deafness | 1 | 2009 | 455 | 0.060 |
Why?
|
Risk Assessment | 4 | 2020 | 23785 | 0.060 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14323 | 0.060 |
Why?
|
Feasibility Studies | 3 | 2020 | 5144 | 0.060 |
Why?
|
Multivariate Analysis | 2 | 2015 | 12138 | 0.060 |
Why?
|
Aortic Aneurysm | 1 | 2009 | 637 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2018 | 7407 | 0.060 |
Why?
|
Laryngoscopy | 1 | 2009 | 703 | 0.060 |
Why?
|
Body Mass Index | 1 | 2021 | 12794 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5280 | 0.050 |
Why?
|
Stroke Volume | 1 | 2016 | 5444 | 0.050 |
Why?
|
Embolization, Therapeutic | 1 | 2012 | 1394 | 0.050 |
Why?
|
Prognosis | 2 | 2020 | 29369 | 0.050 |
Why?
|
Phenotype | 1 | 2020 | 16440 | 0.050 |
Why?
|
Anesthesia, General | 1 | 2009 | 1142 | 0.050 |
Why?
|
Intraoperative Complications | 1 | 2009 | 1180 | 0.050 |
Why?
|
Research Design | 1 | 2017 | 6118 | 0.050 |
Why?
|
Cardiac Imaging Techniques | 1 | 2024 | 275 | 0.050 |
Why?
|
Young Adult | 6 | 2021 | 57732 | 0.050 |
Why?
|
Databases, Factual | 2 | 2015 | 7899 | 0.050 |
Why?
|
Fibrinolytic Agents | 2 | 2021 | 2169 | 0.050 |
Why?
|
Partial Thromboplastin Time | 1 | 2021 | 205 | 0.050 |
Why?
|
Athletic Performance | 1 | 2021 | 99 | 0.040 |
Why?
|
Glasgow Coma Scale | 1 | 2022 | 575 | 0.040 |
Why?
|
Receptors, Interleukin-6 | 1 | 2021 | 225 | 0.040 |
Why?
|
Depression | 1 | 2019 | 7920 | 0.040 |
Why?
|
Hemorrhage | 2 | 2021 | 3570 | 0.040 |
Why?
|
Anesthetics, Intravenous | 1 | 2022 | 396 | 0.040 |
Why?
|
Adolescent | 6 | 2021 | 86822 | 0.040 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2006 | 1879 | 0.040 |
Why?
|
Acute Kidney Injury | 1 | 2011 | 1883 | 0.040 |
Why?
|
Survival Rate | 3 | 2021 | 12751 | 0.040 |
Why?
|
Coma | 1 | 2022 | 486 | 0.040 |
Why?
|
Thrombophilia | 1 | 2021 | 304 | 0.040 |
Why?
|
Pulmonary Medicine | 1 | 2020 | 218 | 0.040 |
Why?
|
Morbidity | 1 | 2023 | 1757 | 0.040 |
Why?
|
Age Factors | 4 | 2020 | 18302 | 0.040 |
Why?
|
Intermittent Positive-Pressure Ventilation | 1 | 2017 | 14 | 0.040 |
Why?
|
Catheterization | 1 | 2023 | 1428 | 0.040 |
Why?
|
Workflow | 1 | 2023 | 841 | 0.040 |
Why?
|
Air Pressure | 1 | 2017 | 74 | 0.040 |
Why?
|
Aerosols | 1 | 2020 | 632 | 0.040 |
Why?
|
Heme | 1 | 2019 | 301 | 0.040 |
Why?
|
Carcinoma, Renal Cell | 1 | 2012 | 3176 | 0.040 |
Why?
|
Fluid Therapy | 1 | 2021 | 590 | 0.040 |
Why?
|
California | 1 | 2021 | 1395 | 0.040 |
Why?
|
Vasoconstrictor Agents | 1 | 2020 | 650 | 0.030 |
Why?
|
Australia | 1 | 2020 | 1277 | 0.030 |
Why?
|
Plasma | 1 | 2020 | 582 | 0.030 |
Why?
|
Lung Volume Measurements | 1 | 2017 | 375 | 0.030 |
Why?
|
Fluoroscopy | 1 | 2020 | 947 | 0.030 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2020 | 468 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13173 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2012 | 4273 | 0.030 |
Why?
|
Internationality | 1 | 2021 | 987 | 0.030 |
Why?
|
Airway Obstruction | 1 | 2020 | 655 | 0.030 |
Why?
|
Brain Ischemia | 1 | 2009 | 3128 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2020 | 1864 | 0.030 |
Why?
|
Long-Term Care | 1 | 2019 | 623 | 0.030 |
Why?
|
Patient Care Team | 2 | 2020 | 2484 | 0.030 |
Why?
|
Adenosine | 1 | 2019 | 825 | 0.030 |
Why?
|
Echocardiography | 2 | 2017 | 4949 | 0.030 |
Why?
|
Eating | 1 | 2021 | 1537 | 0.030 |
Why?
|
Ultrasonography | 2 | 2020 | 5918 | 0.030 |
Why?
|
Holidays | 1 | 2013 | 41 | 0.030 |
Why?
|
Supine Position | 1 | 2014 | 202 | 0.030 |
Why?
|
Odds Ratio | 2 | 2017 | 9701 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2022 | 2114 | 0.030 |
Why?
|
Laser Therapy | 1 | 2020 | 1092 | 0.030 |
Why?
|
Incidence | 2 | 2023 | 21162 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2023 | 2614 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 1984 | 0.030 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2018 | 616 | 0.030 |
Why?
|
Cognition Disorders | 1 | 2007 | 3974 | 0.030 |
Why?
|
Sleep | 2 | 2019 | 4712 | 0.030 |
Why?
|
Premedication | 1 | 2013 | 254 | 0.030 |
Why?
|
Operating Rooms | 1 | 2019 | 784 | 0.030 |
Why?
|
Sex Factors | 2 | 2021 | 10454 | 0.030 |
Why?
|
Survival Analysis | 2 | 2021 | 10187 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1868 | 0.020 |
Why?
|
Leisure Activities | 1 | 2013 | 305 | 0.020 |
Why?
|
Fenoldopam | 1 | 2011 | 7 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 25540 | 0.020 |
Why?
|
Comorbidity | 2 | 2020 | 10475 | 0.020 |
Why?
|
Affect | 1 | 2019 | 1477 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2017 | 1287 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2022 | 4343 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4883 | 0.020 |
Why?
|
Propensity Score | 1 | 2017 | 1872 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2022 | 3803 | 0.020 |
Why?
|
Demography | 1 | 2014 | 1639 | 0.020 |
Why?
|
Patient Compliance | 1 | 2020 | 2680 | 0.020 |
Why?
|
Mortality | 1 | 2021 | 2881 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2020 | 5840 | 0.020 |
Why?
|
Seizures | 1 | 2022 | 2910 | 0.020 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2017 | 1026 | 0.020 |
Why?
|
Bronchoscopes | 1 | 2009 | 64 | 0.020 |
Why?
|
Renal Replacement Therapy | 1 | 2011 | 246 | 0.020 |
Why?
|
Hemolysis | 1 | 2011 | 423 | 0.020 |
Why?
|
Optical Fibers | 1 | 2009 | 135 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6482 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 2017 | 1185 | 0.020 |
Why?
|
Stents | 1 | 2020 | 3299 | 0.020 |
Why?
|
Trauma Centers | 1 | 2013 | 920 | 0.020 |
Why?
|
Venous Thromboembolism | 1 | 2021 | 1822 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3427 | 0.020 |
Why?
|
Laryngoscopes | 1 | 2009 | 146 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2019 | 3033 | 0.020 |
Why?
|
Stroke | 1 | 2009 | 9887 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12455 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 6968 | 0.020 |
Why?
|
Patient Discharge | 1 | 2019 | 3411 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2011 | 1178 | 0.020 |
Why?
|
Health Status | 1 | 2019 | 4050 | 0.020 |
Why?
|
Massachusetts | 1 | 2018 | 8706 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8449 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2016 | 15146 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2023 | 21857 | 0.020 |
Why?
|
Cardiomyopathies | 1 | 2016 | 1922 | 0.020 |
Why?
|
Mental Health | 1 | 2019 | 3150 | 0.010 |
Why?
|
Colectomy | 1 | 2009 | 671 | 0.010 |
Why?
|
Patient Care Planning | 1 | 2009 | 902 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3688 | 0.010 |
Why?
|
Cervical Vertebrae | 1 | 2009 | 968 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 19907 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 29427 | 0.010 |
Why?
|
Glucose | 1 | 2011 | 4354 | 0.010 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2009 | 1387 | 0.010 |
Why?
|
Clinical Competence | 1 | 2013 | 4713 | 0.010 |
Why?
|
Quality of Life | 1 | 2019 | 13162 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 36038 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3307 | 0.010 |
Why?
|
Kidney | 1 | 2011 | 6985 | 0.010 |
Why?
|
Regression Analysis | 1 | 2003 | 6363 | 0.010 |
Why?
|
Blood Pressure | 1 | 2009 | 8468 | 0.010 |
Why?
|
Atrial Fibrillation | 1 | 2009 | 5147 | 0.010 |
Why?
|
Algorithms | 1 | 2009 | 13905 | 0.000 |
Why?
|
Animals | 1 | 2019 | 166825 | 0.000 |
Why?
|